Peripheral blood mononuclear cells from SSc patients produced cytokines and growth factors in response to soluble type 1 collagen in vitro that elicited reduced MMP1 production by SSc dermal fibroblasts (Brown et al., 2012), pointing to additional forms of MMP1 regulation. This evidence concerns the gene MMP1 and systemic sclerosis.